Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Find out which S&P 500 ETF has the lowest expense ratio and how it affects retirement investing. This intro covers why costs matter for long-term gains and what to compare when choosing an ETF.
27,916 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
NuScale Power faces a high-stakes decade as regulators, financiers, and utilities weigh SMR potential. This article l...
Tilray Brands is targeting a milestone $1.2 billion in annual revenue next year. This article digs into how the compa...
Missouri Sen. Josh Hawley has launched a formal inquiry into FICO’s pricing of mortgage credit scores, seeking FTC sc...
ONE Sotheby’s International Realty expands into New Jersey by acquiring Callaway Henderson Sotheby’s International Re...
Crypto dollars are moving from the sidelines to the heart of American politics, with record 2024 spending and a growi...
Oracle enters a critical earnings season with eyes on its AI pivot and data-center expansion. The market has piled on...
Billionaire investor Bill Ackman points to SpaceX's durable cash-flow engines, highlighting a cornerstone of value as...
Boards of public homebuilders are treating scale as a fiduciary test, a shift highlighted by Berkshire Hathaway's Tay...
A major investor moved a sizable stake in Hinge Health, triggering questions about timing and motives. This analysis ...
A tech-focused investor known for hunting winners, billionaire Philippe Laffont just rotated from a high-profile AI p...
Elon Musk has signaled an April roll-out for X Money's early public access, intensifying speculation about crypto fea...